% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Giusti:274203,
author = {F. Giusti and C. Martos and A. Trama and M. Bettio and A.
Sanvisens and R. Audisio and V. Arndt$^*$ and S. Francisci
and C. Dochez and J. Ribes and L. P. Fernández and A. Gavin
and G. Gatta and R. Marcos-Gragera and Y. Lievens and C.
Allemani and R. De Angelis and O. Visser and L. Van Eycken},
collaboration = {E. W. G. o. T. D. Harmonisation},
title = {{C}ancer treatment data available in {E}uropean cancer
registries: {W}here are we and where are we going?},
journal = {Frontiers in oncology},
volume = {13},
issn = {2234-943X},
address = {Lausanne},
publisher = {Frontiers Media},
reportid = {DKFZ-2023-00489},
pages = {1109978},
year = {2023},
abstract = {Population-based cancer registries are responsible for
collecting incidence and survival data on all reportable
neoplasms within a defined geographical area. During the
last decades, the role of cancer registries has evolved
beyond monitoring epidemiological indicators, as they are
expanding their activities to studies on cancer aetiology,
prevention, and quality of care. This expansion relies also
on the collection of additional clinical data, such as stage
at diagnosis and cancer treatment. While the collection of
data on stage, according to international reference
classification, is consolidated almost everywhere, data
collection on treatment is still very heterogeneous in
Europe. This article combines data from a literature review
and conference proceedings together with data from 125
European cancer registries contributing to the 2015 ENCR-JRC
data call to provide an overview of the status of using and
reporting treatment data in population-based cancer
registries. The literature review shows that there is an
increase in published data on cancer treatment by
population-based cancer registries over the years. In
addition, the review indicates that treatment data are most
often collected for breast cancer, the most frequent cancer
in women in Europe, followed by colorectal, prostate and
lung cancers, which are also more common. Treatment data are
increasingly being reported by cancer registries, though
further improvements are required to ensure their complete
and harmonised collection. Sufficient financial and human
resources are needed to collect and analyse treatment data.
Clear registration guidelines are to be made available to
increase the availability of real-world treatment data in a
harmonised way across Europe.},
keywords = {Europe (Other) / big data (Other) / cancer registry (Other)
/ cancer registry data (Other) / cancer treament (Other) /
data harmonisation (Other) / questionnaire (Other)},
cin = {M110 / C071},
ddc = {610},
cid = {I:(DE-He78)M110-20160331 / I:(DE-He78)C071-20160331},
pnm = {313 - Krebsrisikofaktoren und Prävention (POF4-313)},
pid = {G:(DE-HGF)POF4-313},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:36845700},
pmc = {pmc:PMC9944949},
doi = {10.3389/fonc.2023.1109978},
url = {https://inrepo02.dkfz.de/record/274203},
}